欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1516/001
药品名称Valsartan/Hydrochlorothiazid TAD 80 mg/12,5 mg
活性成分
    • Hydrochlorothiazide 12.5 mg
    • Valsartan 80.0 mg
剂型Film-coated tablet
上市许可持有人TAD Pharma GmbH Heinz-Lohmann-Strasse 5 27472 Cuxhaven Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Czech Republic (CZ)
      Valsacombi 80mg/12,5mg potahovaná tableta
    • Bulgaria (BG)
      Co-Valsacor
    • Hungary (HU)
      Co-Valsacor 80/12,5 mg ftabl.
    • Estonia (EE)
    • Lithuania (LT)
      Valsacombi 80 mg/12,5 mg plėvele dengtos tabletės
    • Latvia (LV)
    • Poland (PL)
    • Finland (FI)
    • Norway (NO)
    • Sweden (SE)
    • Greece (EL)
    • Spain (ES)
    • Austria (AT)
      Valsartan/Hydrochlorothiazid Krka 80 mg/12,5 mg Filmtabletten
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
    • Slovenia (SI)
    • Slovak Republic (SK)
      Co-Valsacor 80 mg/12,5 mg filmom obalené tablety
许可日期2009/05/26
最近更新日期2012/08/13
药物ATC编码
    • C09DA03 valsartan and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase